Clinical trial

Immunogenicity of Fluzone High Dose in Immunocompromised Children and Young Adults

NCT01685372

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2012-09-01

PhasePHASE2

Study timeline

Study start (unknown)2012-09-01Date precision: month

Registry last updated2018-01-23

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Solid Organ Transplant Recipient (Liver, Kidney, Heart)unresolved

Rheumatologic Disorderunresolved

Human Immunodeficiency Virus (HIV)unresolved

Bone Marrow Transplant (BMT)unresolved

Dialysisunresolved

Interventions

Fluzone High DoseBIOLOGICAL

FluzoneBIOLOGICAL

Sponsors & collaborators

University of Colorado, Denverlead sponsor

Colorado Clinical & Translational Sciences Institutecollaborator

Mapped research locations

AuroraColorado, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01685372 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.